TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-kappa B Dependent Induction of cFLIPL
Josep Maria Lluis, Ulrich Nachbur, Wendy Diane Cook, Ian Edward Gentle, Donia Moujalled, Maryline Moulin, Wendy Wei-Lynn Wong, Nufail Khan, Diep Chau, Bernard Andrew Callus, James Edward Vince, John Silke, David Lawrence Vaux
PLoS ONE | PUBLIC LIBRARY SCIENCE | Published : 2010
Awarded by National Health and Medical Research Council
This work has been funded by the Leukemia and Lymphoma Society, and National Health and Medical Research Council grant #461221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.